Dynamic news
Home >> NEWS >> Dynamic news
Qingdao Blue Bio-medical Park of Beijing Science Park Development (Group) Co. Ltd. Opens -- A technology-based city is pursuing a blue dream; the bio-chemical i
addtime：2015年01月22日 Author:佚名 source：本站原创
The journalist: After a 3-year construction, Qingdao Blue Bio-medical Park Development Co., Ltd. of Beijing Science Park Development (Group) Co. Ltd. held a grand opening ceremony. Wang Hongguang, vice president of Chinese Academy of Science and Technology for Development, Li Qing, director of Development Center for Medical Science and Technology, Ministry of Health, Chen Fei, member of the Standing Committee of Qingdao Municipal Party Committee, and secretary of the Working Committee of Qingdao National High-tech Industrial Development Zone, Guo Yinghui, vice president of Beijing State-owned Assets Management Co., Ltd. and general manager of Beijing Science Park Development (Group) Co. Ltd., etc. attended the opening ceremony.
The Largest Biology Incubation Center Opens
“Upgrade” City-level High-tech Incubator
First-rate incubation center and professional technology platform are the “magic weapons” attracting enterprises. It’s reported that Qingdao Blue Bio-medical Park of Beijing Science Park Development (Group) Co., Ltd. has been recognized as “Qingdao Biotech Drugs Public R&D Platform”, “Qingdao Small Enterprises Start-up (incubation) Base”, “Qingdao High-tech Enterprise Incubator”, “Clinical Medicine Inspection Center of Qingdao National High-tech Industrial Development Zone” and “Qingdao Instrumental Analysis Technology Cooperation Base”.
For the next step, Qingdao Blue Bio-medical Park of Beijing Science Park Development (Group) Co., Ltd. will accelerate steps of investment invitation and it’s expected to build the incubation center into a state-level incubator in 3 to 5 years.
Industrial Service Improves Entrepreneurial Index
Besides the first-rate incubator in China, Qingdao Blue Bio-medical Park will focus on attracting well-known institutions, research centers and companies at home and abroad in the field of national essential drugs, small molecule drugs, protein drugs, genetic recombination drugs, Chinese traditional medicines, drugs of marine biological origin, detection reagents and equipment development, active pharmaceutical ingredient, pharmaceutical excipients, medical materials and equipment, and biologicals, etc.
By resources integration, six industrial service systems in terms of capital, technology, talent, market, policy, and agency built by Qingdao Blue Bio-medical Park will effectively provide intelligence-intensive and innovative service with high added value and strong technology relevance.
The Qingdao Bio-medical Industry Development Fund established with 250 million yuan in the Park will promote integrated incubation and industry transformation of international and national bio-medical innovative projects in Qingdao Blue Bio-medical Park. In addition, financial support from Venture Capital Fund and Angel Fund with 100 million yuan of Qingdao National High-tech Industrial Development Zone, SME loan platform with 500 million yuan of China Development Back, Investment and Loan Union of China Citic Bank and Qingdao Bank, and many other banks cultivates a favorable entrepreneurial environment for enterprises.
Building a model in Bio-medical Industry in China
On the day of the opening ceremony, representatives from over 10 enterprises, including Shanghai Newsummit Biopharma Group Co., Ltd., Orbiepharm Co., Ltd. (Beijing) signed settling agreement successively and settled in Qingdao Blue Bio-medical Park. Over 30 enterprises and public institutions, including China Pharmaceutical Technology Transfer Center, Shandong Pharmaceutical Industry Association, China Development Bank, Beijing Shangdi Bio-medical Park, Qingdao Municipal Science and Technology Commission, Qingdao University, Ocean University of China, Yellow Sea Fisheries Research Institute Chinese Academy of Fishery Sciences, Shanghai Newsummit Biopharma Group Co., Ltd, signed the Qingdao Blue Bio-medical Park of Beijing Science Park Development (Group) Co., Ltd. Alliance Convention together in order to integrate services of policy, industry, academy, research, finance, agency, trade and media and to build a professional and all-round industrial development platform, providing professional value-added services for settled enterprises in the Park. This is undoubtedly “propellant” for settled enterprises.
In the future, Qingdao Blue Bio-medical Park of Beijing Science Park Development (Group) Co., Ltd. will attract 50 large- and medium-sized enterprises, and 200 small- and medium-sized R&D enterprises to build a bio-medical industrial cluster focusing on life science. At the same time, we will build National Overseas Students Start-up Park, “Thousands of People Plan” and Qingdao Entrepreneurship Demonstration Base. We aim to create jobs for 35,000 people and become a model in the Chinese bio-medical industry. Industry and trade income will be 10 billion yuan.
The Largest Biology Incubation Center Opens
Qingdao Blue Bio-medical Park of Beijing Science Park Development (Group) Co., Ltd. covers an area of 165.6 hectares, including the incubation center, industrial district and living quarter. The largest incubator of bio-medical industry covering an area of 120,000 ㎡and invested by Beijing Science Park Development (Group) Co., Ltd. (800 million yuan) has attracted 18 enterprises settled in the Park and sighed contracts with 27 enterprises which will settle there and the incubation center has successfully attracted potential enterprises. So Qingdao Blue Bio-medical Park, a leader in bio-medical industry, opens.
As the largest incubator of bio-medical industry with advanced planning concept, incubation center of Qingdao Blue Bio-medical Park has a GMP pilot-test platform, GLP R&D space, public experimental platform, laboratories and supporting facilities, which can accommodate 80 to 100 small and medium-sized start-up companies and R&D institutions. Also bio-medical R&D experimental facilities with a total value of 50 million yuan are equipped and these facilities can meet enterprises’ needs in the study of molecular biology, genomics, proteomics, cell biology, etc. At the same time, the Park has started to build a public technology service platform with billions of yuan including technology platforms of molecular biology, protein research, genomics, cell biology, analytical test, pilot process research, which fuels the development of bio-medical industry in Qingdao.
As the largest incubator of bio-medical industry with advanced planning concept, incubation center of Qingdao Blue Bio-medical Park has a GMP pilot-test platform, GLP R&D space, public experimental platform, laboratories and supporting facilities, which can accommodate 80 to 100 small and medium-sized start-up companies and R&D institutions. Also bio-medical R&D experimental facilities with a total value of 50 million yuan are equipped and these facilities can meet enterprises’ needs in the study of molecular biology, genomics, proteomics, cell biology, etc. At the same time, the Park has started to build a public technology service platform with billions of yuan including technology platforms of molecular biology, protein research, genomics, cell biology, analytical test, pilot process research, which fuels the development of bio-medical industry in Qingdao.
“Upgrade” City-level High-tech Incubator
First-rate incubation center and professional technology platform are the “magic weapons” attracting enterprises. It’s reported that Qingdao Blue Bio-medical Park of Beijing Science Park Development (Group) Co., Ltd. has been recognized as “Qingdao Biotech Drugs Public R&D Platform”, “Qingdao Small Enterprises Start-up (incubation) Base”, “Qingdao High-tech Enterprise Incubator”, “Clinical Medicine Inspection Center of Qingdao National High-tech Industrial Development Zone” and “Qingdao Instrumental Analysis Technology Cooperation Base”.
For the next step, Qingdao Blue Bio-medical Park of Beijing Science Park Development (Group) Co., Ltd. will accelerate steps of investment invitation and it’s expected to build the incubation center into a state-level incubator in 3 to 5 years.
Industrial Service Improves Entrepreneurial Index
Besides the first-rate incubator in China, Qingdao Blue Bio-medical Park will focus on attracting well-known institutions, research centers and companies at home and abroad in the field of national essential drugs, small molecule drugs, protein drugs, genetic recombination drugs, Chinese traditional medicines, drugs of marine biological origin, detection reagents and equipment development, active pharmaceutical ingredient, pharmaceutical excipients, medical materials and equipment, and biologicals, etc.
By resources integration, six industrial service systems in terms of capital, technology, talent, market, policy, and agency built by Qingdao Blue Bio-medical Park will effectively provide intelligence-intensive and innovative service with high added value and strong technology relevance.
The Qingdao Bio-medical Industry Development Fund established with 250 million yuan in the Park will promote integrated incubation and industry transformation of international and national bio-medical innovative projects in Qingdao Blue Bio-medical Park. In addition, financial support from Venture Capital Fund and Angel Fund with 100 million yuan of Qingdao National High-tech Industrial Development Zone, SME loan platform with 500 million yuan of China Development Back, Investment and Loan Union of China Citic Bank and Qingdao Bank, and many other banks cultivates a favorable entrepreneurial environment for enterprises.
Building a model in Bio-medical Industry in China
On the day of the opening ceremony, representatives from over 10 enterprises, including Shanghai Newsummit Biopharma Group Co., Ltd., Orbiepharm Co., Ltd. (Beijing) signed settling agreement successively and settled in Qingdao Blue Bio-medical Park. Over 30 enterprises and public institutions, including China Pharmaceutical Technology Transfer Center, Shandong Pharmaceutical Industry Association, China Development Bank, Beijing Shangdi Bio-medical Park, Qingdao Municipal Science and Technology Commission, Qingdao University, Ocean University of China, Yellow Sea Fisheries Research Institute Chinese Academy of Fishery Sciences, Shanghai Newsummit Biopharma Group Co., Ltd, signed the Qingdao Blue Bio-medical Park of Beijing Science Park Development (Group) Co., Ltd. Alliance Convention together in order to integrate services of policy, industry, academy, research, finance, agency, trade and media and to build a professional and all-round industrial development platform, providing professional value-added services for settled enterprises in the Park. This is undoubtedly “propellant” for settled enterprises.
In the future, Qingdao Blue Bio-medical Park of Beijing Science Park Development (Group) Co., Ltd. will attract 50 large- and medium-sized enterprises, and 200 small- and medium-sized R&D enterprises to build a bio-medical industrial cluster focusing on life science. At the same time, we will build National Overseas Students Start-up Park, “Thousands of People Plan” and Qingdao Entrepreneurship Demonstration Base. We aim to create jobs for 35,000 people and become a model in the Chinese bio-medical industry. Industry and trade income will be 10 billion yuan.
